Cabot Corp. logo

Cabot Corp.

CBT

NYSEBasic MaterialsChemicals - Specialty

Previous close

$85.19

+$0.26 · +0.31%

Aug 21, 4:00 PM ET

Pre-market

$85.69

+$0.50 · +0.59%

Aug 24, 4:42 AM ET

CBT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

83

Deep Value

Momentum

56

Neutral

Sentiment

61

Bullish

Risk resilience

67

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions. It also provides specialty carbons for use in inks, coatings, plastics, adhesives, toners, batteries, and displays; conductive additives and fumed alumina used in lead acid and lithium-ion batteries for electric vehicles; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; and fumed alumina for use in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries. In addition, it offers aerogel, a hydrophobic, silica-based particle to use in various thermal insulation and specialty chemical applications; masterbatch and conductive compound products that are used in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; and inkjet colorants for inkjet printing applications, as well as carbon nanotubes and fumed metal oxides. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.

Industry
Chemicals - Specialty
Sector
Basic Materials
Headquarters
US
CEO
Sean D. Keohane
Listed since
Nov 5, 1980
Employees
4,064

Market position

Day range

Current $85.19

52-week range

Current $85.19

Open
$85.48
Previous close
$84.93
Volume
250.88K
0.51× average
Average volume
491.75K
Average daily volume
Market cap
4.4B USD
Beta
0.84
Market reference 1
50-day average
$88.1102
-3.31% below average
200-day average
$76.4683
+11.41% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
5.04B USD
EV / EBITDA
6.35×
Earnings yield
8.11%
Free cash flow yield
9.57%

Profitability & efficiency

Return on equity
21.35%
Return on assets
8.68%
Return on invested capital
13.03%

Financial health

Current ratio
1.61×
Altman Z-score
3.32
Piotroski F-score
6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends27%19%11%3%Gross margin, FY2021: 23.44%Gross margin, FY2022: 20.48%Gross margin, FY2023: 21.34%Gross margin, FY2024: 24.04%Gross margin, FY2025: 25.32%Operating margin, FY2021: 13.32%Operating margin, FY2022: 9.00%Operating margin, FY2023: 13.38%Operating margin, FY2024: 15.37%Operating margin, FY2025: 16.73%Net margin, FY2021: 7.33%Net margin, FY2022: 4.84%Net margin, FY2023: 11.32%Net margin, FY2024: 9.51%Net margin, FY2025: 8.91%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 23.44%. Gross margin FY2022 20.48%. Gross margin FY2023 21.34%. Gross margin FY2024 24.04%. Gross margin FY2025 25.32%. Operating margin FY2021 13.32%. Operating margin FY2022 9.00%. Operating margin FY2023 13.38%. Operating margin FY2024 15.37%. Operating margin FY2025 16.73%. Net margin FY2021 7.33%. Net margin FY2022 4.84%. Net margin FY2023 11.32%. Net margin FY2024 9.51%. Net margin FY2025 8.91%.

Income trends

Revenue

3.71B USD-7.04%

Operating income

621M USD+1.14%

Net income

331M USD-12.89%
Income trends across reported periods4.73B USD3.09B USD1.44B USD−202.2M USDRevenue, FY2021: 3.41B USDRevenue, FY2022: 4.32B USDRevenue, FY2023: 3.93B USDRevenue, FY2024: 3.99B USDRevenue, FY2025: 3.71B USDOperating income, FY2021: 454M USDOperating income, FY2022: 389M USDOperating income, FY2023: 526M USDOperating income, FY2024: 614M USDOperating income, FY2025: 621M USDNet income, FY2021: 250M USDNet income, FY2022: 209M USDNet income, FY2023: 445M USDNet income, FY2024: 380M USDNet income, FY2025: 331M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 3.41B USD. Revenue FY2022 4.32B USD. Revenue FY2023 3.93B USD. Revenue FY2024 3.99B USD. Revenue FY2025 3.71B USD. Operating income FY2021 454M USD. Operating income FY2022 389M USD. Operating income FY2023 526M USD. Operating income FY2024 614M USD. Operating income FY2025 621M USD. Net income FY2021 250M USD. Net income FY2022 209M USD. Net income FY2023 445M USD. Net income FY2024 380M USD. Net income FY2025 331M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue3.71B USD3.99B USD3.93B USD4.32B USD3.41B USD
Cost of goods sold2.77B USD3.03B USD3.09B USD3.44B USD2.61B USD
Gross profit940M USD960M USD839M USD885M USD799M USD
Research and development59M USD63M USD57M USD55M USD56M USD
Selling, general, and administrative260M USD283M USD253M USD258M USD289M USD
Operating expenses319M USD346M USD313M USD496M USD345M USD
Interest income27M USD32M USD31M USD11M USD8M USD
Interest expense76M USD81M USD90M USD56M USD49M USD
Depreciation and amortization154M USD151M USD144M USD146M USD160M USD
Operating income621M USD614M USD526M USD389M USD454M USD
Net income331M USD380M USD445M USD209M USD250M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
91%
10 beats, 1 miss, 0 met estimates
Average EPS surprise
+4.66%
11 comparable reports
Latest EPS result
1.67
Estimate 1.65 · Beat by 1.21%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates1.981.761.541.32Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 3, 2025: actual 1.76, estimate 1.74, surprise +1.15%, Beat. Q2 2025, reported May 5, 2025: actual 1.9, estimate 1.85, surprise +2.70%, Beat. Q3 2025, reported Aug 4, 2025: actual 1.9, estimate 1.82, surprise +4.40%, Beat. Q4 2025, reported Nov 3, 2025: actual 1.7, estimate 1.68, surprise +1.19%, Beat. Q1 2026, reported Feb 3, 2026: actual 1.53, estimate 1.4, surprise +9.29%, Beat. Q2 2026, reported May 5, 2026: actual 1.61, estimate 1.47, surprise +9.52%, Beat. Q3 2026, reported Aug 3, 2026: actual 1.67, estimate 1.65, surprise +1.21%, Beat. Q4 2026, reported Nov 2, 2026: actual —, estimate 1.51, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.07B980.73M894.34M807.96MQ1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 3, 2025: actual 955M USD, estimate 1.03B USD, surprise -6.93%, Miss. Q2 2025, reported May 5, 2025: actual 936M USD, estimate 955M USD, surprise -1.99%, Miss. Q3 2025, reported Aug 4, 2025: actual 923M USD, estimate 977.64M USD, surprise -5.59%, Miss. Q4 2025, reported Nov 3, 2025: actual 899M USD, estimate 930M USD, surprise -3.33%, Miss. Q1 2026, reported Feb 3, 2026: actual 849M USD, estimate 887.04M USD, surprise -4.29%, Miss. Q2 2026, reported May 5, 2026: actual 904M USD, estimate 900.31M USD, surprise +0.41%, Beat. Q3 2026, reported Aug 3, 2026: actual 982M USD, estimate 943.16M USD, surprise +4.12%, Beat. Q4 2026, reported Nov 2, 2026: actual —, estimate 912.97M USD, surprise —, Comparison unavailable.

CBT news

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$1.78

2025 complete year+25.4% since 2021

2026 partial: $0.9225

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Aug 28, 2026

$0.4725

Quarterly

Record Aug 28, 2026 · Payment Sep 11, 2026

Dividend

Ex-dividend May 29, 2026

$0.4725

Quarterly

Record May 29, 2026 · Payment Jun 12, 2026

Dividend

Ex-dividend Feb 27, 2026

$0.45

Quarterly

Record Feb 27, 2026 · Payment Mar 13, 2026

Dividend

Ex-dividend Nov 28, 2025

$0.45

Quarterly

Record Nov 28, 2025 · Payment Dec 12, 2025

Dividend

Ex-dividend Aug 29, 2025

$0.45

Quarterly

Record Aug 29, 2025 · Payment Sep 11, 2025

Dividend

Ex-dividend May 30, 2025

$0.45

Quarterly

Record May 30, 2025 · Payment Jun 13, 2025

ETFs holding CBT

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research CBT

research.disclaimer